Individual patients with a shared ailment can respond very differently to the same drug. This highly variable clinical response to drugs is reflective of the current ‘one size fits all’ approach adopted in much of clinical care, and effectively represents an extremely large unmet medical need across the disease spectrum.
AlphaBiomics is developing precision medicine solutions based on the gut microbiome of patients in order to deliver safer and more efficacious drug therapies.
Company Details
- Employees
- 3
- Founded
- 2018
- Address
- 204 Southgate Road, London,england,united Kingdom
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- alphabiomics.com
- HQ
- London, England
Alphabiomics Questions
Alphabiomics's website is alphabiomics.com
Alphabiomics's LinkedIn profile is https://uk.linkedin.com/company/alphabiomics
Alphabiomics has
3 employees.
View email and phone details for 3
employees at Alphabiomics.
Alphabiomics's industry is
Biotechnology Research
Alphabiomics's top competitors are
Indigo-Med,
Adp Diagnostics Ltd,
Agile Life Sciences,
Diaqual Ltd,
Pacifi Ltd.,
Biohit Healthcare Ltd,
Vitec Microgenix,
Fast Mdx Ltd,
Future Studio,
Ajm Med-I-Caps.
Alphabiomics's support email address is info@alphabiomics.com
Alphabiomics's categories are Biotechnology Research
Alphabiomics's founding year is 2018
